Therapy of AML in Patients Older Than 60 Years: Randomized Comparison of a Double Induction With Daunorubicin and AraC (as Continuous Infusion) With a Double Induction With Mitoxantrone and Intermittent, Medium High Dose AraC
Randomized comparison of the two protocols.
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Complete remission rate
Ulrich S. Schuler, PD Dr. med.
University Hospital Dresden, Germany
Germany: Federal Institute for Drugs and Medical Devices